-
Signature
-
/s/ Jeffrey J. Pochowicz, Attorney-in-fact
-
Issuer symbol
-
MCD
-
Transactions as of
-
05 Nov 2025
-
Net transactions value
-
-$572,178
-
Form type
-
4
-
Filing time
-
07 Nov 2025, 12:08:49 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Steijaert Manuel JM |
EVP - President, IOM |
MCDONALD'S CORPORATION, 110 NORTH CARPENTER STREET, CHICAGO |
/s/ Jeffrey J. Pochowicz, Attorney-in-fact |
07 Nov 2025 |
0001876859 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MCD |
Common Stock |
Options Exercise |
$2,427,730 |
+9,581 |
+208% |
$253.39 |
14,187 |
05 Nov 2025 |
Direct |
|
| transaction |
MCD |
Common Stock |
Options Exercise |
$945,809 |
+3,553 |
+25% |
$266.20 |
17,740 |
05 Nov 2025 |
Direct |
|
| transaction |
MCD |
Common Stock |
Sale |
$3,945,716 |
-13,134 |
-74% |
$300.42 |
4,606 |
05 Nov 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MCD |
Options (Right to Buy) |
Options Exercise |
$0 |
-9,581 |
-65% |
$0.000000 |
5,193 |
05 Nov 2025 |
Common Stock |
9,581 |
$253.39 |
Direct |
F2 |
| transaction |
MCD |
Options (Right to Buy) |
Options Exercise |
$0 |
-3,553 |
-18% |
$0.000000 |
16,687 |
05 Nov 2025 |
Common Stock |
3,553 |
$266.20 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: